167 related articles for article (PubMed ID: 17370564)
1. AmBisome: adds to the body of knowledge and familiarity of use.
Richardson M
Acta Biomed; 2006; 77 Suppl 4():3-11. PubMed ID: 17370564
[No Abstract] [Full Text] [Related]
2. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
Fernández Fernández A; Esteban Montero S
Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
[No Abstract] [Full Text] [Related]
3. Drug treatment of the systemic mycoses.
Newberry WM
Semin Drug Treat; 1972; 2(3):313-29. PubMed ID: 4617926
[No Abstract] [Full Text] [Related]
4. [Chemotherapy of mycoses of the inner organs].
Scholer HJ
Schweiz Med Wochenschr; 1968 Apr; 98(16):602-11. PubMed ID: 5688589
[No Abstract] [Full Text] [Related]
5. [Refractory respiratory tract infections. 9. Chemotherapy of recent respiratory tract infections. d. Mycoses].
Mori T; Takahashi M; Ikemoto H
Nihon Rinsho; 1987 Mar; 45(3):627-31. PubMed ID: 3298740
[No Abstract] [Full Text] [Related]
6. [Treatment and prevention of generalized mycoses].
Kullberg BJ; van 't Wout JW
Ned Tijdschr Geneeskd; 1995 Jul; 139(28):1436-41. PubMed ID: 7623930
[No Abstract] [Full Text] [Related]
7. Antifungal therapy: from amphotericin B to present.
Dismukes WE
Trans Am Clin Climatol Assoc; 1993; 104():166-77; discussion 177-9. PubMed ID: 1343440
[No Abstract] [Full Text] [Related]
8. AmBisome today: expanding the perspectives on liposomal amphotericin B.
Richardson M
Acta Biomed; 2006; 77 Suppl 2():3-4. PubMed ID: 16918058
[No Abstract] [Full Text] [Related]
9. Amphotericin B plus fluconazole for HIV-associated cryptococcal meningitis.
Harrison TS
Clin Infect Dis; 2009 Jun; 48(12):1784-6. PubMed ID: 19441979
[No Abstract] [Full Text] [Related]
10. [New aspects of infections caused by Aspergillus and Mucor and other filamentous fungi in immunosuppressed patients].
Bouza E
Rev Clin Esp; 1995 Oct; 195 Suppl 3():15-25. PubMed ID: 9441301
[No Abstract] [Full Text] [Related]
11. Managing the challenges of invasive fungal infections.
Herbrecht R
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():1-2. PubMed ID: 16701981
[No Abstract] [Full Text] [Related]
12. Fungus among us.
Pizzoli F
Posit Aware; 2001; 12(3):35-6. PubMed ID: 11686118
[No Abstract] [Full Text] [Related]
13. Lipid formulations of amphotericin B and solid organ transplant recipients with central nervous system cryptococcosis.
Soonawala D; Landman GW; Van't Wout JW
Clin Infect Dis; 2010 Jun; 50(11):1544; author reply 1544-5. PubMed ID: 20433357
[No Abstract] [Full Text] [Related]
14. [Current treatment of systematic mycoses].
Clemente González C
Med Clin (Barc); 1983 Oct; 81(13):589-94. PubMed ID: 6361398
[No Abstract] [Full Text] [Related]
15. Amphotericin B: the higher the dose, the higher the toxicity.
Pasqualotto AC
Clin Infect Dis; 2008 Oct; 47(8):1110; author reply 1110-1. PubMed ID: 18800934
[No Abstract] [Full Text] [Related]
16. Cryptococcal meningitis in acute lymphoblastic leukemia.
Malhotra P; Chauhan S; Bhatt P; Varma N; Chakrabarti A; Kumari S; Jain S; Varma S
J Assoc Physicians India; 2004 Oct; 52():831-2. PubMed ID: 15909862
[TBL] [Abstract][Full Text] [Related]
17. [Generalized mycoses and their therapy].
Braun W
Z Gesamte Inn Med; 1977 Jul; 32(14):Suppl: 222-4 contd. PubMed ID: 919648
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
19. The experience is CLEAR.
Chandrasekar P
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248
[TBL] [Abstract][Full Text] [Related]
20. Compassionate use protocol initiated for AmBisome.
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
